Form 6-K Galmed Pharmaceuticals For: Aug 25
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Stocks fall as higher oil prices, Treasury yields weigh
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
Galmed Pharmaceuticals terminates licensing deal, plans minority stake
August 25, 2025 8:16 AM EDTGalmed Pharmaceuticals Ltd. (NASDAQ: GLMD) terminated a licensing agreement with Entomus s.r.o. for development and commercialization of a Self-Emulsifying Drug Delivery System formulation, according to a company statement.
The pharmaceutical company ended the binding term sheet following additional due diligence and... More
Galmed Pharmaceuticals terminates licensing deal, plans minority stake
August 25, 2025 7:41 AM EDTGalmed Pharmaceuticals Ltd. (NASDAQ: GLMD) terminated a licensing agreement with Entomus s.r.o. for development and commercialization of a Self-Emulsifying Drug Delivery System formulation, according to a company statement.
The pharmaceutical company ended the binding term sheet following additional due diligence and... More
